Search
for

    Sort by

    Research 151–180 of 1000+

    1. Phase II study of safusidenib erbumine in patients with chemotherapy- and radiotherapy-naïve isocitrate dehydrogenase 1-mutated WHO grade 2 gliomas Neuro-Oncology · 2025 · 1 citations
    2. Sacituzumab Tirumotecan Across Gynecologic Malignancies: One Target, Multiple Diseases Current Oncology Reports · 2026
    3. Extraction, purification, structural characterization, and bioactivities of Ginkgo biloba leave polysaccharides: A review International Journal of Biological Macromolecules · 2024
    4. Phytochemical and pharmacological properties of Jatropha dioica Journal of plant science and phytopathology · 2023
    5. Current Progress Regarding Cordyceps militaris, Its Metabolite Function, and Its Production Applied Sciences · 2024 · 1 citations
    6. Innovation and Biodiversity: Patent Trends in Therapeutic and Cosmetic Use of Scientifically Relevant Pantanal Plants Plants · 2026
    7. Tumor Necrosis Factor-α and Interleukin-1 Antagonists Alleviate Inflammatory Skin Changes Associated with Epidermal Growth Factor Receptor Antibody Therapy in Mice Cancer Research · 2009 · 53 citations
    8. Cutaneous manifestations associated with immune checkpoint inhibitors Frontiers in immunology · 2023 · 14 citations
    9. A phase 1b study of chemo-immunotherapy with pegylated liposomal doxorubicin and Pembrolizumab in estrogen receptor positive metastatic breast cancer Cancer Research Communications · 2026
    10. Hibiscus Rosa Sinensis Linn. International Journal of Health Sciences (IJHS) · 2022
    11. The impact of exercise on tolerability of systemic treatment in metastatic colorectal cancer: A literature review Journal of Cancer Survivorship · 2026
    12. BRAF Inhibitor Dabrafenib in Patients with Metastatic <i>BRAF</i>-Mutant Thyroid Cancer Thyroid · 2014 · 188 citations
    13. Pharmacological Activity of Cepharanthine 2023 · 3 citations
    14. <i>Ziziphus</i>: A prospective multi application fruit tree Vegetos · 2014 · 4 citations
    15. Phytochemical, Ethnomedicinal, and Therapeutic Potential of Darmana Turki (Artemisia maritima L.) - A Critical Study 2023
    16. Turmeric Essential Oil Constituents as Potential Drug Candidates: A Comprehensive Overview of Their Individual Bioactivities Molecules · 2024 · 17 citations
    17. 4‐octyl itaconate alleviates cisplatin‐induced ferroptosis possibly via activating the NRF2/HO‐1 signalling pathway Journal of Cellular and Molecular Medicine · 2024 · 1 citations
    18. Lignans and Neolignans: Plant secondary metabolites as a reservoir of biologically active substances Pharmacological Research · 2019 · 112 citations
    19. The Evolution of Emerging Nanovesicle Technologies for Enhanced Delivery of Molecules into and across the Skin Pharmaceutics · 2024 · 1 citations
    20. Next-Gen Therapeutics for Skin Cancer: Nutraceuticals Nutrition and Cancer · 2018 · 10 citations
    21. Medicinal uses, pharmacological activities, phytochemistry, and the molecular mechanisms of Punica granatum L. (pomegranate) plant extracts: A review Biomedicine & Pharmacotherapy · 2022 · 202 citations
    22. Redefining hormone resistance in prostate cancer Therapeutic Advances in Medical Oncology · 2009 · 38 citations
    23. Platinum-Induced Peripheral Neuropathy (PIPN): ROS-Related Mechanism, Therapeutic Agents, and Nanosystems Frontiers in Molecular Biosciences · 2021 · 13 citations
    24. Potential Health Benefit of Dates Based on Human Intervention Studies: A Brief Overview Haya: the Saudi journal of life sciences · 2022 · 3 citations
    25. A comprehensive overview of Hibiscus-rosa-sinensis and its uses: A review International Journal of Advanced Biochemistry Research · 2025 · 1 citations
    26. 12-O-Tetradecanoylphorbol-13-acetate Induces Apoptosis in Renal Epithelial Cells through a Growth Signal Conflict Which Is Prevented by Activated ras1 Archives of Biochemistry and Biophysics · 2001 · 4 citations
    27. Isoginkgetin, a natural biflavonoid from Ginkgo biloba, inhibits inflammatory response in endothelial cells via suppressing NF-κB activation Acta Pharmacologica Sinica · 2025 · 2 citations
    28. NDA Submission of Vepdegestrant (ARV-471) to U.S. FDA: The Beginning of a New Era of PROTAC Degraders Journal of Medicinal Chemistry · 2025 · 45 citations
    29. Small cell lung cancer: Results of a phase II study of 1,2,4 triglycidylurazol Cancer Chemotherapy and Pharmacology · 1986 · 6 citations
    30. Ziziphus spina-christi (Christ’s Thorn Jujube) Elsevier eBooks · 2017